Table 3.
Dosage form | Determination of components | Detection method (wavelength) | Reference |
---|---|---|---|
Wuzi Yanzong Wan | Hyperoside, Gomisin A | HPLC (360, 250 nm) | Chinese Pharmacopoeia (2020) |
Hyperoside, Kaempferide, Schisandrin, Schisandrin A, Schisandrin B | HPLC/PDA (360, 250 nm) | 23 | |
Hyperoside, Quercitrin, kaempferol-3-rutinoside, Schisandrin, Schisandrin A, Schisandrin B | HPLC/PDA (254 nm) | 24 | |
Betaine | HPLC (192 nm) | 25 | |
Scopoletin | HPLC-FLD (343 nm,458 nm) | 26 | |
Wuzi Yanzong Pian | Hyperoside, Gomisin A | HPLC (360,250 nm) | Chinese Pharmacopoeia (2020) |
Schisandrin A | HPLC (230 nm) | Xin Yao Zhuan Zheng Biao Zhun | |
Wuzi Yanzong Jiaonang | Schisandrin | HPLC (254 nm) | Xin Yao Zhuan Zheng Biao Zhun |
Wuzi Yanzong Keli | Rutin | HPLC (254 nm) | Xin Yao Zhuan Zheng Biao Zhun |
Notes: HPLC: high performance liquid chromatography; PDA: photo-diode array.